Scilex issues warrant to Oramed for 100,000 shares at $20.00 in exchange for payment deferral

Scilex Holding Co

Warrant for 100,000 shares at $20.00 issued to Oramed Pharmaceuticals for deferring an amortization payment originally due Oct 1, 2025.
Deferred payment was made in November 2025; warrant is immediately exercisable and expires Dec 13, 2029.
Exercise price subject to anti-dilution adjustments with a floor of $8.22; beneficial ownership limit set at 4.99%.
Company commits to file a resale registration statement for the underlying shares within 30 days or by March 31, 2026.
Warrant agreement includes most-favored-nations clause for six months and standard change-of-control repurchase right.

item 1.01 item 3.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Scilex Holding Co issued 100,000 shares of the Company’s common stock of warrant to Oramed Pharmaceuticals Inc..

Security: warrant
Shares: 100,000 shares of the Company’s common stock
Purchaser: Oramed Pharmaceuticals Inc.

Exact text from the filing

the issuance of the February 2026 Warrant was made, and the issuance of the shares of Common Stock underlying the February 2026 Warrants will be made, in reliance on the exemption from registration pursuant to Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Scilex Holding Co entered into Warrant Agreement with Oramed Pharmaceuticals Inc. (effective 2026-02-19).

Action: entry
Counterparty: Oramed Pharmaceuticals Inc.
Effective: 2026-02-19

Exact text from the filing

On February 19, 2026, Scilex Holding Company (the “ Company ”) entered into a Warrant Agreement (the “ Warrant Agreement ”) with Oramed Pharmaceuticals Inc. (“ Oramed ”).

View on SEC.gov

Browse all equity issuances →

Scilex Holding Co filing history →

Source: SEC EDGAR

accession 0001193125-26-061371

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.